Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Joaquín Gómez-Ramírez"'
Autor:
María Posada-González, Joaquín Gómez-Ramírez, Manuel Luque-Ramírez, Mercedes Guijarro, Elena Martín-Pérez, Ana Rodríguez-Sánchez, Iñigo García-Sanz, Eduardo Larrañaga
Publikováno v:
Surgery Research and Practice, Vol 2014 (2014)
Parathyroid carcinoma is a very rare malignancy. It has been associated with hyperparathyroidism-jaw tumour syndrome, familial isolated primary hyperparathyroidism, and multiple endocrine neoplasia type 1 (MEN-1) and 2A (MEN-2A) syndromes. We report
Externí odkaz:
https://doaj.org/article/52513e9b9e174367b12eef365d2d734f
Autor:
Joaquín Gómez-Ramírez, Paula Cubillo Heras, Raquel Arranz Jiménez, Luz Divina Juez Saez, Elisa York Pineda, Camilo Zapata Syro, Constantino Fondevila Campo
Publikováno v:
Langenbeck's Archives of Surgery. 408
Autor:
Elena Martín-Pérez, Álvaro Valdés de Anca, Joaquín Gómez-Ramírez, Belén Porrero, Alberto G Barranquero, Lara Blanco Terés, Sara Corral, José Luis Muñoz de Nova
Publikováno v:
The American Journal of Surgery. 222:959-963
Background Preoperative administration of a saturated solution of potassium iodide (SSKI) is recommended in the guidelines for the management of hyperthyroidism due to Graves’ disease. Studies addressing its effect on complications after thyroidect
Autor:
Alberto G. Barranquero, Paula Pastor, Ana Ortega, Sara Corral, Joaquín Gómez Ramírez, Patricia Luengo, Belén Porrero, Luis Jacobo Cabañas
Publikováno v:
Cirugía Española.
Autor:
Luis Gorospe, María Eugenia Olmedo-García, Gemma María Muñoz-Molina, Pilar Garrido-López, María Eugenia Rioja-Martín, Laura Mezquita, Isabel García-Gómez-Muriel, Héctor Gerardo Pian-Arias, Joaquín Gómez-Ramírez
Publikováno v:
The Annals of Thoracic Surgery. 109:e397-e399
Pembrolizumab, a programmed death 1 inhibitor, has been shown to have clinically significant efficacy in different types of cancer, providing long-term survival benefit for patients with lung cancer. Herein, we report the development of a primary thy
Autor:
Sergio Salido Fernandez, Joaquín Gómez-Ramírez, Irene Osorio-Silla, Carmen Sánchez García, Ricardo Pardo García, Adela Valdazo-Gómez
Publikováno v:
Surgery. 171(4)
Background Bone disease in primary hyperparathyroidism is a clear indication for surgical treatment. However, it is not known whether surgery benefits hypercalcemic primary hyperparathyroidism and normocalcemic primary hyperparathyroidism equally. Th
Publikováno v:
Cirugía Española. 96:395-400
Resumen El analisis citologico tiene un papel fundamental en el estudio de los nodulos tiroideos. Sin embargo, hasta un 30% de estos muestran citologias indeterminadas (Bethesda III o IV). En estos casos, se realizan cirugias diagnosticas que unicame
Autor:
Joaquín Gómez Ramírez, Sonia Rivas Fidalgo, Ana Alicia Tejera Hernández, Mariano Díaz Miguel, María Luisa Sánchez de Molina Rampérez
Publikováno v:
Cirugía Española. 96:387-390
Autor:
Belén Porrero Guerrero, Laura María Tortolero Giamate, Patricia Luengo Pierrard, Jordi Nuñez Nuñez, Joaquín Gómez Ramírez
Publikováno v:
Journal of the Endocrine Society
Introduction: Osteitis fibrosa cystica (OFC) is the most serious bone involvement of primary hyperparathyroidism (PHPT), it is characterized by subperiosteal resorption, lytic lesions and the appearance of brown tumors; this is why, in some cases, th
Autor:
Radu Mihai, Joaquín Gómez-Ramírez
Publikováno v:
Langenbeck's Archives of Surgery. 402:1103-1108
In recent years, there has been increasing interest in understanding the implications of diagnosing normocalcaemic primary hyperparathyroidism (nPHPT). Many patients hope that nPHPT might explain some of their symptoms, but surgeons hesitate to offer